CVC Capital Partners
http://www.cvc.com/Content/En/General/Home.aspxCVC Capital Partners is a global private equity firm with over $25 billion in funds. The firm focuses on management buyouts and invests in companies with the following attributes: enterprise value of €250 million to €10 billion; talented, experienced and motivated management and workforce; opportunities for growth either organically or through acquisition; stable cash flows; and above average returns on internally invested capital. The firm was founded in 1981 and is headquartered in Luxembourg.
View Older Stories View More Recent Stories
-
Intertrust misses targets as attrition rates hurt productivity
-
Bespoke Partners Achieves Banner Year of Growth and Expansion
-
Twitter buys minority stake in digital advertising firm Aleph
-
Aéropostale-owner Authentic Brands withdraws IPO plans
-
Form SC 13D Paysafe Ltd Filed by: CVC Capital Partners VI Ltd
-
Enel teams up with Intesa Sanpaolo for Italy payments firm Mooney
-
Soccer-Real, Barca and Bilbao sue LaLiga over CVC deal
-
Mediaocean Appoints Strategic Marketing Executive David Berkowitz as SVP Corporate Marketing and Communications
-
Soccer-Spain's LaLiga clubs approve CVC 1.9 billion euro capital injection
-
Advent, Carlyle considering bid for DuPont's $12 billion unit - Bloomberg News
-
Alvotech to go Public Via Merger with Oaktree Acquisition Corp. II (OACB.U)
-
Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company
-
Cyber protection leader Acronis expands Board with the appointment of Lisbeth McNabb
-
Razer execs offer to take firm private, valuing it at $3.2 billion
-
A Powerful Investment Alliance of Aztiq and Innobic Acquires Alvogen’s Shares in Lotus and Adalvo in a US$475m Deal
-
Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse
-
KKR, CVC Capital in talks to jointly bid for Telecom Italia – Bloomberg News
-
Booking Holdings (BKNG) To Acquire Etraveli Group for EUR 1.63B
-
Booking Holdings Enters Into An Agreement With CVC Capital Partners To Acquire Etraveli Group
-
CVC's target Intertrust confirms having received multiple bids
-
Intertrust confirms it has received multiple expressions of interest for a potential public cash offer; in discussions with all parties
-
Antares Supports Investment in CFGI by CVC Capital Partners Fund VIII
-
CVC, HPS to buy stake in Authentic Brands at $12.7 billion valuation
-
Unilever (UL) to sell its Tea business, ekaterra, to CVC Capital Partners Fund VIII for EUR4.5 bn
-
Unilever bags $5 billion deal with CVC for tea business
-
CVC Capital Is Said To Reach Deal For $5B Unilever Tea Unit - Bloomberg
-
Take-private deal could value Razer at up to $4.5 billion -sources
-
Altice founder Drahi seeks bigger stake in Britain's BT - sources
-
Intertrust and CVC have entered into exclusive discussions in relation to a potential public cash offer of EUR 18.00 per share
-
Toshiba's lurch from crisis to crisis since 2015
-
Bespoke Partners Opens East Coast Office, Welcomes New Vice President
-
Mediaocean named a Leader in 2021 Gartner® Magic Quadrant™ for Ad Tech and named in the Gartner Peer Insights Customers’ Choice: Ad Tech
-
Mediaocean named a Leader in 2021 Gartner® Magic Quadrant™ for Ad Tech and named in the Gartner Peer Insights Customers’ Choice: Ad Tech
-
Acronis announces the most significant year in the company's history
-
VelocityEHS Addresses Complex ESG Questions & Concerns with New Virtual Conference
-
VelocityEHS Addresses Complex ESG Questions & Concerns with New Virtual Conference
-
Bespoke Partners Welcomes New Partner
-
FanClub Sports Finally Announces its Long-Awaited Public Launch
-
Italian gaming group Sisal files for IPO on Milan Stock Exchange
-
Alvotech Beats Back AbbVie’s Trade Secrets Lawsuit
-
Bespoke Partners Celebrates 10th Anniversary
-
Activist investor Elliott owns "significant" stake in Toshiba as review conducted
-
KBRA Assigns an AA- Rating to BNP Paribas Fortis SA/NV Participation in the Uncommitted, Secured Revolving Credit Facility to CVC Capital Partners VII
-
Sebia and Metafora biosystems form Strategic partnership to Develop Advanced In Vitro Diagnostics tests
-
Alvotech Provides Update on FDA Action Regarding AVT02, Proposed High-Concentration Biosimilar to Humira® (adalimumab)
-
AlbaCore Capital Group Continues to Expand with Three Senior Hires
-
Alvotech Welcomes Positive CHMP Opinion for AVT02, a Proposed Biosimilar to Humira®
-
CFGI Announces Investment from CVC Capital Partners Fund VIII to Drive Continued Growth
-
Alvotech Announces Positive Top-Line Results for Switching Study Between Proposed Biosimilar AVT02 and Humira (TEVA)
-
Alvotech Announces Positive Top-Line Results for Switching Study Between Proposed Biosimilar AVT02 and Humira®

